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ABSTRACT 
The present study was design to evaluate the effect of Zingiber officinale hydro-alcoholic extract as well as its interaction with conventional anxiolytic and 
antidepressant drugs using tail suspension test and forced swim test (FST) and to evaluate the possible mechanisms involved in its actions. The rhizomes of 
ginger were collected and authenticated.  Extraction of dried rhizomes was carried out using soxhlet apparatus to obtain its Hydro alcoholic extract.  The 
extract of Zingiber officinale showed the significant antidepressant activity comparable to the standard drug. The oral administration of Zingiber officinale 
extract at 150 mg/ kg and 300 mg/kg respectively as compared to the control treated group showed an antidepressant activity comparable to that of standard 
drug. The antidepressant effects of Zingiber officinale extract seem to be mainly associated with the activation of dopamineergic system and possess potential 
anxiolytic and antidepressant activities. 
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INTRODUCTION 
Depression is an important global public-health issue and is 
associated with substantial disability 
1, 2. It is a chronic illness 
that affects mood, thoughts, physical health and behavior of 
any individual and has been estimated to affect upto 21% of 
the world’s population 
3. Synthetic antidepressants taken in 
appropriate doses are often associated with their anticipated 
side  effects  like  dry  mouth,  inability  in  driving  skills, 
constipation and sexual dysfunction 
4 and majority of patients 
are  reluctant  to  take  this  treatment.  Accordingly,  natural 
medicinal  plants  may  be  important  sources  of  novel 
antidepressant drugs and the usage of plant extracts may be 
proven better in the management of stress and depression. In 
oriental  countries,  many  medicinal  plants  from  natural 
resources,  especially  Chinese  medicine,  such  as  Plantago 
asiatica,  Scrophularia  ningpoensis,  and  Hypercarium 
perforatum  were  successfully  used  to  treat  or  prevent 
depression-like disorders 
5, 6.  
Ginger, the rhizome of Zingiber officinale, is one of the most 
widely used species of the ginger family (Zingiberaceae) and 
is  a  common  condiment  for  various  foods  and  beverages. 
Ginger has a long history of medicinal use dating back 2,500 
years in China and India for conditions such as headaches, 
nausea, rheumatism, and colds 
7. Characterized in traditional 
Chinese medicine as spicy and hot, ginger is claimed to warm 
the body and treat cold extremities, improve a weak and tardy 
pulse, address a pale complexion, and strengthen the body 
after  blood  loss
8.  Ginger  contains  a  number  of  pungent 
constituents  and  active  ingredients.  Steam  distillation  of 
powdered ginger produces ginger oil, which contains a high 
proportion  of  sesquiterpene  hydrocarbons,  predominantly 
zingiberene
9. The major pungent compounds in ginger, from 
studies  of  the  lipophilic  rhizome  extracts,  have  yielded 
potentially  active  gingerols,  which  can  be  converted  to 
shogaols, zingerone, and paradol
10. The compound 6-gingerol 
appears  to  be  responsible  for  its  characteristic  taste. 
Zingerone and shogaols are found in small amounts in fresh 
ginger and in larger amounts in dried or extracted products. 
The  mechanism  underlying  ginger’s  anti-emetic  activity  is 
not  clearly  understood,  but  the  aromatic,  spasmolytic, 
carminative, and absorbent properties of ginger suggest it has 
direct  effects  on  the  gastrointestinal  tract
11.  No  study 
indicates  ginger  influenced  within  the  vestibular  or 
oculomotor  system
12.  A  mechanism  involving  the  central 
nervous system cannot be ruled out, considering several of 
ginger’s components antagonize serotonin type-3 receptors; 
however,  this  has  not  been  clearly  demonstrated
13-15.  The 
compounds  6-gingerol  and  6-shogaol  have  been  shown  to 
have  a  number  of  pharmacological  activities,  including 
antipyretic, analgesic, antitussive, and hypotensive effects
10. 
Ginger extracts exhibit inhibition of platelet aggregation and 
thromboxane synthesis in vitro
11-15 which has led to concerns 
ginger  extracts  may  prolong  bleeding;  however,  several 
European  studies  using  ginger  orally  did  not  find  any 
significant anticoagulant effects in vivo 
16. Daily consumption 
of 15 gm raw ginger rhizome or 40 gm cooked rhizome by 
healthy volunteers for two weeks failed to decrease platelet 
cyclooxygenase  activity
17.  Similarly,  differences  were  not 
found  in  bleeding  time,  platelet  count,  and  platelet 
functioning  when  eight  healthy  volunteers  were  given  a 
single  2-gram  dose  of  the  dried  rhizome  or  placebo 
18.  In 
continuation of our research on Zingiber officinale, we have 
investigated the probable mechanisms of antidepressant-like 
activity  of  Zingiber  officinale  in  behavioral  models  of 
depression using laboratory rats. The study would possibly 
help to establish that hydro alcoholic extract of the Zingiber 
officinale rhizomes which have potential therapeutic value for 
the management of depressive disorders. 
MATERIALS AND METHODS 
Collection and Preparation of extract 
Zingiber officinale was collected  from Bilaspur, India. The 
rhizomes were washed; air dried under shade and powdered 
with the help of Grinder at School of Pharmacy, Chouksey 
Engineering  College,  Bilaspur,  India.  Powdered  rhizomes 
were  weighed  and  packed  in  soxhlet.  Solvent  used  for 
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50:50  respectively.  Extraction  was  continued  at  the 
temperature of 50°C till clear solvent was observed in siphon 
tube.  Extract  was  concentrated  in  water  bath  at  40°C. 
Concentrated extract was dried at 40°C in hot air oven. Dried 
extract was packed in an air tight container.  
Animals 
The experimental protocol was approved by the Institutional 
Animal  Ethics  Committee  (IAEC).  Regd.No. 
1275/ac/09/CPCSEA  of  School  of  Pharmacy,  Chouksey 
Engineering  College,  Bilaspur,  India.  Adult  male  Swiss 
Albino rats weighing 150-200 gm from our breeding stock 
were used in this study. They were housed in polypropylene 
cages  under  standard  conditions  (23  ±  2 .C, humidity  60–
70%, 12 h light/dark cycles). They had free access to food 
and water ad libitum. The animals were acclimatized for a 
period of 7 days before the study. The study was conducted 
according  to  the  Indian  National  Science  Academy 
Guidelines for the use and care of experimental animals. 
Acute dermal toxicity – fixed dose procedure 
The  acute  dermal  toxicity  study  was  carried  out  in  adult 
female  albino  rats  by  “fix  dose”  method  of  OECD 
(Organization for Economic Co-operation and Development) 
Guideline  No.434.  Latex  of  the  rhizomes  of  Zingiber 
officinale was given orally at dose level 2000 mg/kg. 
Selection of Dose and standard drug preparation 
For the assessment of antidepressant activity, dose level was 
chosen in such a way that, dose was approximately one tenth 
of  the  maximum  dose  during  acute  toxicity  studies  (150-
300mg/kg/day). Imipramine was used as the reference drug 
for  evaluating  the  antidepressant  activity.  Imipramine  was 
powdered and made into suspension in distilled water using. 
Forced Swim Test (FST)  
The  method  described  in  the  literature  was  used  in  our 
study
19. Each animal was placed individually in 5 liter glass 
beakers, filled with water upto a height of 15 cm and were 
observed  for  duration  of  6  minutes.  The  duration  of 
immobility  was  recorded  during  the  last  4  minutes  of  the 
observation  period.  The  mouse  was  considered  immobile 
when  it  floated  motionlessly  or  made  only  those  moments 
necessary to keep its head above the water surface. The water 
was changed after each test. 
Tail suspension test (TST)  
The method described by Steru et al. was used in our study. 
The animals were hung by the tail on a plastic string 75 cm 
above  the  surface  with  the  help  of  an  adhesive  tape.  The 
duration  of  immobility  was  observed  for  a  period  of  8 
minutes. The duration of immobility was recorded during the 
last  6  minutes  of  the  observation  period.  Mice  were 
considered to be immobile  only  when they hung passively 
and were completely motionless 
20. 
Groping of Animal 
Animals were divided in to three groups, each group 
consisting of 6 rats. 
Group I: Received no treatment and served as control, 1% 
gum acacia (10ml/kg) 
Group II: Received test drug Zingiber officinale (150 
mg/kg/) per orally 
Group  III:  Received  test  drug  Zingiber  officinale  (300 
mg/kg/) per orally 
Group  IV:  Received  standard  drug  i.e.  imipramine 
(10mg/kg) 
Statistical analysis 
The mean ± S.E.M. statistical significance of difference of 
control  and  test  data  was  determined  by  using  ANOVA 
followed by Dunnet’s multiple comparison test. P< 0.05 was 
considered to be significant. A probability value of 0.05 or 
less was taken to indicate statistical significance. 
RESULTS AND DISCUSSION 
In  both  the  test  i.e.  Forced  Swim  Test  (FST)  and  Tail 
suspension test (TST) the extract shortened the immobility 
period during the forced swimming test in comparison with 
control  and  exhibited  a  dose  dependent  antidepressant 
activity.    A  significant  (P<0.01)  decrease  in  duration  of 
immobility was observed as compared to that of control. The 
extract at a dose of 300 mg/kg body weight is found to be 
effective  nearly  similar  to  that  of  conventional  drug 
imipramine. The results are summarized in Table 1. Mood 
disorders are one of the most common mental illnesses, with 
a lifetime risk of 10% in general population. Prevalence of 
depression  alone  in  general  population  is  estimated  to  be 
around  5%  with  suicide  being  one  of  the  most  common 
outcomes 
21-28. Most of the drugs that are currently being used 
in the treatment of depression have adverse effects that affect 
the quality of life of the patient. This leads to patient’s non-
compliance  to  medication,  which  further  complicates  the 
problem 
29-30.  Ayurveda  mentions  a  number  of  single  and 
compound drug formulations of plant origin that are used in 
the treatment of psychiatric disorders 
31 and are claimed to 
have a better side-effect profile than conventional drugs. 
Zingiber officinale (150 and 300 mg/kg) significantly (P  < 
0.001) and dose dependently decreased the immobility time 
as  compared  to  control  mice  (Table  1).  The  extract  at  the 
dose  of  300  mg/kg  showed  the  almost  same  activity  as 
imipramine (P > 0.05), in decreasing immobility period. Tail 
suspension test 
26 represents the behavioural despair model, 
claimed  to  test  is  based  on  the  observation  that  animals, 
following  initial  escape  oriented  movements,  develop  an 
immobile  posture  when  placed  in an  inescapable  chamber. 
The  immobility  is  thought  to  reflect  either  a  failure  of 
persistence in escape-directed behaviour (that is, behavioural 
despair)  or  the  development  of  passive  behaviour  that 
disengages  the  animal  from  active  forms  of  coping  with 
stressful stimuli 
32. It has been argued that the TST is less 
stressful  than  FST  and  has  greater  pharmacological 
sensitivity 
33.  Remarkably,  TST  detects  the anti-immobility 
effects of a wide array of antidepressants, including tricyclic 
antidepressants (TCA), selective serotonin reuptake inhibitors 
(SSRI),  monoamine  oxidase  inhibitors  (MAOI),  electro-
convulsive  shock  (ECS)  and  even  atypical  antidepressants. 
Thus, the activity of Zingiber officinale could involve one of 
the mechanisms of the established agents as described above. 
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Table 1. Effect of Zingiber officinale on duration of immobility time in the tail suspension test (TST) and Forced Swim Test (FST) using rats.. 
 
Group 
 
Dose mg/kg/ 
(S), TST 
Duration of Immobility 
 
(S), FST 
Duration of Immobility 
 
1% gum acacia  (10ml/kg)  193±3.51  178±1.52 
Zingiber officinale  150  141±5.06  146±1.73 
Zingiber officinale  300  135±9.29  122±4.35 
Imipramine  10  132±4.93  119±1.15 
Values represented mean ± S.E.M. (n=6), P<0.05, P<0.01 vs. control (group 1). 
 
CONCLUSION 
As medicinal plants have their importance since ancient time, 
people using it from various ways as a source of medicine. 
From the above valuable animal study, we conclude that the 
plant  extract  Zingiber  officinale  show  a  significant 
antidepressant activity in TST and FST models of depression. 
Thus,  we  can  say  that  Zingiber  officinale  significantly 
reduces the immobility period in both TST and FST. 
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